Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5655974 | 0.83 | NAAA (0.72) | MAPK1NAAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11038520 | 0.83 | NAAA (0.72) | MAPK1NAAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3291433 | 0.83 | POLB (0.61) | MAPK1ALDH1A1POLB | |
| SCHEMBL13293971 | 0.82 | NAAA (0.52) | MAPK1NAAAAPPCYP1A2CYP2C9 | |
| SCHEMBL446310 | 0.81 | CDK1 (0.70) | MAPK1NAAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2158919 | 0.81 | ALDH1A1 (0.64) | MAPK1NAAAAPPCYP1A2CYP2C9 | |
| SCHEMBL2164508 | 0.81 | NAAA (0.57) | MAPK1NAAAAPPCYP1A2CYP2C9 | |
| SCHEMBL31661686 | 0.81 | NAAA (0.57) | MAPK1NAAAAPPCYP1A2CYP2C9 | |
| SCHEMBL30481047 | 0.81 | MAPK1 (0.63) | MAPK1NAAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL29036025 | 0.81 | MAPK1 (0.63) | MAPK1NAAACYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7727558-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-7727558-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-7727558-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-20070141022-A1 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | EMISPHERE TECHNOLOGIES, INC. | 2007-06-21 | — | — | US | disclosed |
| US-20070141022-A1 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | EMISPHERE TECHNOLOGIES, INC. | 2007-06-21 | — | — | US | disclosed |
| US-20070141022-A1 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | EMISPHERE TECHNOLOGIES, INC. | 2007-06-21 | — | — | US | disclosed |
| US-7208483-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208483-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-7208483-B2 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-20030232085-A1 | Polymeric delivery agents and delivery agent compounds | EMISPHERE TECHNOLOGIES, INC. | 2003-12-18 | — | — | US | disclosed |
| US-6627228-B1 | Polymeric delivery agents and delivery agents compounds | EMISPHERE TECHNOLOGIES, INC. | 2003-09-30 | — | — | US | disclosed |
| EP-1146860-A4 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | EMISPHERE TECH INC (US) | 2002-07-03 | — | — | EP | disclosed |
| EP-1146860-A2 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | Emisphere Technologies, Inc. (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000040203-A2 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | EMISPHERE TECHNOLOGIES, INC. (US) | 2000-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141022-A1 | POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS | LPXN, PGF, TTPA | MAPK1 4176/4885NAAA 1681/4885APP 3159/4885 |
| US-20030232085-A1 | Polymeric delivery agents and delivery agent compounds | LPXN, PGF, TTPA | MAPK1 4176/4885NAAA 1681/4885APP 3159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.